Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine/Gemcitabine vs Docetaxel/Gemcitabine in Advanced NSCLC
NCT00441740Phase 3Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Apr 2004
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Hellenic Oncology Research Group. Started Apr 2004; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00441740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00441740.